- ISIN
- US74019P1084
- CUSIP
- 74019P108
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Mar 28, 2019
Highlights
- Market Cap
- $148.79M
- Enterprise Value
- $52.54M
- EPS (TTM)
- -$2.95
- Total Revenue (TTM)
- $45.07M
- Gross Profit (TTM)
- $32.19M
- EBITDA (TTM)
- -$30.02M
- Year Range
- $3.53 - $8.82
- Target Price
- $19.00
- ROA (TTM)
- -30.92%
- ROE (TTM)
- -58.46%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
DTIL Performance Chart
Precision BioSciences, Inc. (DTIL) is up 45.2% since the beginning of the year. At $6 per share, DTIL is trading 31.5% below its 52-week high of $9. Investors who bought $1,000 worth of DTIL shares 5 years ago would now be looking at an investment worth $18.
Loading charts...
Returns By Period
Precision BioSciences, Inc. (DTIL) has returned 45.19% so far this year and 17.28% over the past 12 months.
Precision BioSciences, Inc.
- 1D
- -4.43%
- 1M
- -20.84%
- YTD
- 45.19%
- 6M
- 19.37%
- 1Y
- 17.28%
- 3Y*
- -35.49%
- 5Y*
- -55.07%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
DTIL Monthly Returns History
Based on dividend-adjusted daily data since Mar 28, 2019, DTIL's average daily return is -0.10%, while the average monthly return is -1.54%.
Historically, 38% of months were positive and 63% were negative. The best month was Nov 2019 with a return of +173.8%, while the worst month was Dec 2024 at -47.7%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 11 months.
On a daily basis, DTIL closed higher 46% of trading days. The best single day was Nov 1, 2023 with a return of +29.6%, while the worst single day was Dec 9, 2019 at -51.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.81% | 6.06% | 30.95% | 30.00% | -2.52% | -13.34% | 45.19% | ||||||
| 2025 | 31.50% | 7.58% | -11.50% | 18.24% | -14.36% | -13.04% | 13.10% | 3.16% | 12.65% | 47.83% | -33.33% | -23.53% | 9.19% |
| 2024 | 3.15% | 63.79% | -26.70% | -23.23% | 23.92% | -24.57% | -2.06% | 14.17% | -17.65% | -4.46% | -14.84% | -47.74% | -65.21% |
| 2023 | -2.52% | -3.45% | -32.71% | 11.46% | -11.90% | -28.92% | 9.89% | -19.98% | -26.21% | -9.82% | 15.37% | 2.79% | -69.33% |
| 2022 | -35.54% | -10.90% | -27.53% | -35.39% | -15.58% | -4.76% | -8.13% | 9.52% | -19.25% | 7.69% | -2.14% | -13.14% | -83.92% |
| 2021 | 45.32% | -1.32% | -13.46% | -10.24% | 13.35% | 18.90% | -21.25% | 27.48% | -8.19% | -17.76% | -4.53% | -18.32% | -11.27% |
Benchmark Metrics
Precision BioSciences, Inc. has an annualized alpha of -37.32%, beta of 1.34, and R2 of 0.10 versus S&P 500 Index. Calculated based on daily prices since March 29, 2019.
- This stock participated in 199.18% of S&P 500 Index downside but only -22.99% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.10 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -37.32%
- Beta
- 1.34
- R²
- 0.10
- Upside Capture
- -22.99%
- Downside Capture
- 199.18%
Return for Risk
Risk / Return Rank
DTIL ranks 50 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Precision BioSciences, Inc. (DTIL) and compare them to S&P 500 Index.
| DTIL | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.25 | 2.24 | -1.99 |
Sortino ratioReturn per unit of downside risk | 0.85 | 3.07 | -2.22 |
Omega ratioGain probability vs. loss probability | 1.10 | 1.41 | -0.31 |
Calmar ratioReturn relative to maximum drawdown | 0.30 | 2.93 | -2.63 |
Martin ratioReturn relative to average drawdown | 0.56 | 13.52 | -12.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Precision BioSciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Precision BioSciences, Inc. was 99.39%, occurring on Feb 5, 2026. The portfolio has not yet recovered.
The current Precision BioSciences, Inc. drawdown is 98.98%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.39%Feb 2026 | 6y 2mo | — | 6y 5moDec 2019 - now |
2019 bear market2019 | -64.79%Oct 2019 | 6mo 26d | 1mo 4d | 8moApr 2019 - Nov 2019 |
2019 pullback2019 | -8.47%Dec 2019 | 5d | 1d | 6dNov 2019 - Dec 2019 |
Drawdown Indicators
| DTIL | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.39% | -56.78% | -42.61% |
Max Drawdown (1Y)Largest decline over 1 year | -58.54% | -9.10% | -49.44% |
Max Drawdown (3Y)Largest decline over 3 years | -85.40% | -18.90% | -66.50% |
Max Drawdown (5Y)Largest decline over 5 years | -99.16% | -25.43% | -73.73% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -98.98% | -0.74% | -98.24% |
Average DrawdownAverage peak-to-trough decline | -77.65% | -10.72% | -66.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.78% | 1.97% | +28.81% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Precision BioSciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Precision BioSciences, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for DTIL relative to other companies in the Biotechnology industry. Currently, DTIL has a P/S ratio of 2.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DTIL in comparison with other companies in the Biotechnology industry. Currently, DTIL has a P/B value of 2.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with DTIL
Add Precision BioSciences, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with DTIL